TFF Pharmaceuticals S1 IPO registration | TFFP 20 Aug 19

Search this filing

Filing exhibits

S-1 IPO registration
3.1 Second Amended and Restated Certificate of Incorporation of the Registrant
3.2 Bylaws of the Registrant
3.3 Amended and Restated Bylaws of the Registrant Effective Immediately Following the Closing of This Offering
4.2 Warrant Dated January 24, 2018 Issued to Liquid Patent Advisors, LLC
4.3 Warrant Dated March 13, 2018 Issued to National Securities Corporation
4.4 Warrant Dated March 22, 2018 Issued to National Securities Corporation
4.5 Warrant Dated May 16, 2019 Issued to National Securities Corporation
4.6 Warrant Dated May 23, 2019 Issued to National Securities Corporation
10.1 Engagement Agreement Dated January 26, 2018 Between Liquid Patent Advisors, LLC and the Registrant
10.2 Securities Purchase Agreement Dated March 13, 2018 by and Among the Registrant and the Buyers Named Therein
10.3 Amended and Restated Registration Rights Agreement Dated May 16, 2019 by and Among the Registrant and Certain of Its Stockholders
10.4 Contribution and Subscription Agreement Dated January 24, 2018 Between the Registrant and Lung Therapeutics, Inc.
10.5 Patent License Agreement Dated July 8, 2015 Between Lung Therapeutics, Inc. and the University of Texas at Austin
10.6 TFF Pharmaceuticals, Inc. 2018 Stock Incentive Plan
10.7 Amended and Restated Consulting Agreement Dated December 20, 2018 Between Robert Mills and the Registrant
10.8 Consulting Agreement Dated February 12, 2018 Between DR. Brian Windsor and the Registrant
10.9 Consulting Agreement Dated April 23, 2018 Between Glenn Mattes and the Registrant
10.10 Lease Agreement Dated October 19, 2018
10.11 Executive Employment Agreement Dated December 20, 2018 Between Glenn Mattes and the Registrant
10.12 Securities Purchase Agreement Dated May 16, 2019 by and Among the Registrant and the Buyers Named Therein
10.13 Amendment NO.1 to Patent License Agreement Dated November 30, 2018 Between the Registrant and the University of Texas at Austin
10.14 Employment Agreement, Dated February 15, 2019, by and Between the Registrant and Kirk Coleman
21.1 List of Subsidiaries
23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm

TFF Pharmaceuticals (TFFP) S-1IPO registration